XBIO Xenetic Biosciences, Inc. - 8-K

Item 2.02.

Results of Operations and Financial Condition.

On March 13, 2026, Xenetic Biosciences, Inc. (the
“Company”) issued a press release announcing results for the year ended December 31, 2025.

The full text of the press release is furnished
as Exhibit 99.1 to this Current Report on Form 8-K and hereby incorporated in this Item 2.02 by reference. The information in this Item
2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended,
except as shall be expressly set forth by specific reference in such filing.

FORWARD-LOOKING STATEMENTS

This Form 8-K, including the press release, contains
forward-looking statements that we intend to be subject to the safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. All statements contained in this Form 8-K, including the press release, other than statements of historical facts may constitute
forward-looking statements within the meaning of the federal securities laws. These statements can be identified by words such as “expects,”
“plans,” “projects,” “will,” “may,” “anticipates,” “believes,”
“should,” “intends,” “estimates,” and other words of similar meaning. Any forward-looking statements
contained herein are based on current expectations, and are subject to a number of risks and uncertainties. Many factors could cause
our actual activities, performance, achievements or results to differ materially from the activities and results anticipated in forward-looking
statements. These risks and uncertainties include those described in the “Risk Factors” section as detailed from time to
time in the Company’s reports filed with the Securities and Exchange Commission (“SEC”), including the Company’s
annual report on Form 10-K, periodic quarterly reports on Form 10-Q, current reports on Form 8-K and other documents filed with the SEC.
In addition, forward-looking statements may also be adversely affected by general market factors, general economic and business conditions,
including potential adverse effects of public health issues and geopolitical events, such as the conflicts in the Ukraine and in the
Middle East, on economic activity, competitive product development, product availability, federal and state regulations and legislation,
the regulatory process for new product candidates and indications, manufacturing issues that may arise, patent positions, litigation,
and shareholder activism, among other factors. The forward-looking statements contained in this Form 8-K, including the press release,
speak only as of the date the statements were made, and the Company does not undertake any obligation to update forward-looking statements,
except as required by law.